Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Yellow Fever · Immunization; Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Oregon Health & Science University, Portland, Oregon, United States
Contact: Study coordinator (William Messer, MD PhD) · messer@ohsu.edu · 503-494-2185
Contact: Study coordinator (Sarah Siegel, PhD) · siegels@ohsu.edu · 541-609-0798

Study leads

William Messer, MD PhD
Principal Investigator
Oregon Health and Science University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Improving Vaccine Protection for Adults

Immune System Responses and Trained Immunity After AS01 Administration · Healthy Adult

Abroad (travel likely)RecruitingPHASE2

Singapore, Singapore

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

Yellow Fever Immunization

Abroad (travel likely)RecruitingPHASE3

San Pedro Sula, Honduras · San Pedro Sula, Cortes, Honduras

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Dengue · Chikungunya · Zika Virus Infection

Abroad (travel likely)Recruiting

Phnom Penh, Cambodia

VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)

Yellow Fever Vaccine

Abroad (travel likely)Recruiting

Paris, France